Description
HGF/MET Potentiator · Research Grade · Cognitive Collection →
Dihexa Research Capsules
Captide Labs Dihexa capsules provide researchers with a precisely dosed, encapsulated format of one of the most potent cognition-related peptide analogues investigated in preclinical neuroscience research. Each capsule delivers 10mg of Dihexa at greater than 98% purity, independently verified by HPLC-MS analysis and documented with a full Certificate of Analysis.
Dihexa (CAS 1401708-83-5), also known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, is a small peptide analogue derived from angiotensin IV. It acts as a potentiator of hepatocyte growth factor (HGF) signaling at the MET receptor — a pathway with established roles in synaptogenesis, neuronal survival, and cognitive function. Dihexa has been reported in preclinical literature to be orders of magnitude more potent than BDNF in certain hippocampal synaptogenesis assays.
|
Compound
Dihexa
|
CAS Number
1401708-83-5
|
|
Also Known As
N-hexanoic-Tyr-Ile-(6)aminohexanoic amide
|
Purity
>98% (HPLC-MS Verified)
|
|
Format
Encapsulated Powder
|
Amount Per Capsule
10mg
|
|
Capsules Per Bottle
30
|
Testing Standard
ISO 17025 Accredited Lab
|
|
Other Ingredients
Gelatin (Vegan), Rice Flour, Silicon Dioxide
|
|
What is Dihexa?
Dihexa is a small peptidomimetic compound derived from angiotensin IV (AngIV), developed at Washington State University through structure-activity relationship studies aimed at identifying potent HGF/MET pathway modulators. It was designed to penetrate the blood-brain barrier — a significant challenge for peptide-based neurological research compounds — while retaining potent biological activity at the MET receptor.
The HGF/MET signaling axis plays well-established roles in neuronal development, synaptic plasticity, and neuroprotection. Dihexa’s reported ability to potentiate HGF-mediated MET receptor activation has made it a subject of research interest in models of cognitive decline, neurodegeneration, and hippocampal function — particularly in the context of conditions associated with reduced HGF/MET signaling.
Areas of active investigation
Frequently Asked Questions
For research use only. Not for human consumption, veterinary use, or food/agricultural applications. Not evaluated or approved by the FDA. Not intended to diagnose, treat, cure, or prevent any condition. All purchases are made with the understanding that this compound is strictly for in-vitro research and laboratory use.





Reviews
There are no reviews yet.